Back Login for AI Analysis

    ZBIO (STOCKS)

    Zenas BioPharma, Inc. Common Stock

    $23.684700
    +2.204700 (+10.26%)
    Prev close: $21.480000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Biotechnology
    CEO
    Leon Oliver Moulder
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $1,249.65M
    Employees
    130
    P/E (TTM)
    -5.14
    P/B (TTM)
    4.62
    Dividend Yield
    —
    Technical Indicators
    SMA 10
    —
    SMA 20
    —
    SMA 50
    —
    EMA 9
    —
    EMA 21
    —
    RSI
    —
    MACD State
    —
    Recent News

    No recent news found for this ticker.

    Financial Statements
    TTM (Sep 2025)
    Revenues $15.00M
    Nonoperating Income/Loss $11.04M
    Operating Expenses $215.70M
    Research and Development $161.50M
    Other Operating Expenses $54.20M
    Operating Income/Loss -$200.70M
    Income/Loss From Continuing Operations After Tax -$189.90M
    Income/Loss From Continuing Operations Before Tax -$189.66M
    Net Income/Loss -$189.90M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent -$189.90M
    Net Income/Loss Available To Common Stockholders, Basic -$189.90M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Basic Earnings Per Share $13.67
    Diluted Earnings Per Share $13.67
    Basic Average Shares 51,520,844
    Diluted Average Shares 51,520,844
    Assets $322.02M
    Current Assets $296.64M
    Cash $301.60M
    Noncurrent Assets $25.38M
    Fixed Assets $50.00K
    Non-current Prepaid Expenses $12.88M
    Other Non-current Assets $12.44M
    Liabilities $125.59M
    Current Liabilities $52.42M
    Accounts Payable $6.44M
    Wages $8.76M
    Other Current Liabilities $37.22M
    Noncurrent Liabilities $73.17M
    Equity $196.43M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $196.43M
    Liabilities And Equity $322.02M
    Net Cash Flow From Operating Activities -$158.47M
    Net Cash Flow From Operating Activities, Continuing -$158.47M
    Net Cash Flow From Investing Activities -$162.26M
    Net Cash Flow From Investing Activities, Continuing -$162.26M
    Net Cash Flow From Financing Activities $76.29M
    Net Cash Flow From Financing Activities, Continuing $76.29M
    Net Cash Flow -$244.44M
    Net Cash Flow, Continuing -$244.44M
    Comprehensive Income/Loss -$190.02M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$190.02M
    Other Comprehensive Income/Loss -$190.02M